Table 4.
Univariable and multivariate analyses of predictive factors for OS.
| Univariable | Multivariate | Univariable | ||
|---|---|---|---|---|
| Variable | 95%CI | P | Variable | 95%CI |
| Female | 0.70 (0.13-3.71) | 0.676 | ||
| Ann Arbor stage III-IV | 1.12 (0.13-9.66) | 0.921 | ||
| B symptom | 1.84 (0.34-9.87) | 0.477 | ||
| LDH>ULN | 2.94 (0.49-17.76) | 0.239 | ||
| ECOG ≥ 2 | 0.26 (0.032-2.14) | 0.211 | ||
| Extranodal sites ≥1 | 0.68 (0.13-3.61) | 0.648 | ||
| IPI 3-5 | 3.00 (0.57-15.64) | 0.193 | ||
| Marrow involvement | 0.96 (0.17-5.36) | 0.966 | ||
| Prior lines of chemotherapy>2 | 1.81 (0.34-9.71) | 0.490 | ||
| Prior ASCT | 0.26 (0.04-1.66) | 0.153 | ||
| Grade of CRS 3-4 | 8.29 (0.66-103.30) | 0.100 | ||
| Response Non-CR | 3.02 (0.58-15.61) | 0.187 | ||
| DE | 9.56 (1.69-53.99) | 0.011* | 10.37 (1.17- 92.25) | 0.041* |
| MYC + | 7.17 (1.32-38.99) | 0.023* | 8.64 (0.96- 77.44) | 0.042* |
| BCL2 + | 4.30 (0.73-25.37) | 0.107 | ||
| MTV> 42.000 | 6.25 (1.171-33.33) | 0.032* | 0.207 | |
| TLG> 55.000 | 4.49 (0.78-25.79) | 0.092 | ||
| GLZLM_LZHGECT>721377.442 | 4.27 (0.72-25.29) | 0.110 | ||
| GLCM_EnergyPET> 0.001 | 3.43 (0.33-35.45) | 0.301 | ||
| NGLDM_ContrastPET> 0.473 | 9.24 (1.81-47.15) | 0.008* | 0.196 | |
| GLZLM_ZLNUPET> 16.294 | 3.83 (0.58-25.22) | 0.162 |
*p < 0.05.